Archive for the ‘faked data’ Category
Three doctors at the Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh are losing a paper based on phone calls to the Drug Information Unit, a phone line that patients could call to learn more about the drugs they were considering taking.
The catch: It was all made up.
According to an investigation by the Hindustan Times, the phone was disconnected between 2012 and May 2014, though ‘data’ for the paper was allegedly collected in 2013. We imagine that would make it difficult to answer the 56 calls the paper claims a junior resident took over the course of a month.
The HT reports that the Journal of Clinical & Diagnostic Research paper, “Drug Information Unit as an Effective Tool for Promoting Rational Drug Use,” is being retracted, and that the dean has asked for an official investigation. We’ve reached out to the journal, and will update with any new information.
This isn’t the worst of recent allegations against hospital staff at PGIMER. Orthopedics professor Vishal Kumar was accused of being in bed with pharmaceutical companies and harassing several employees. From the HT: Read the rest of this entry »
Two Oxford journals have now put out three more retractions for ob-gyn and former University of Florida professor Nasser Chegini, who has been under ORI investigation since at least 2012. That makes a total of five retractions, by our count.
Here is the notice for “The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression” in Molecular Human Reproduction: Read the rest of this entry »
Former University of Tokyo researcher Shigeaki Kato continues to put big numbers on the board.
Last month, we reported on his 26th, 27th, and 28th retractions, all in Nature Cell Biology and cited close to 700 times. Yesterday, EMBO Journal and EMBO Reports published a total of five more retractions for the endocrinology researcher, who resigned from the university in 2012 following investigations found he had faked images.
A retraction has appeared for Jens Förster, the former University of Amsterdam social psychologist whose work has come under serious scrutiny by two official committees.
Here’s the notice for 2012’s “Sense Creative! The Impact of Global and Local Vision, Hearing, Touching, Tasting and Smelling on Creative and Analytic Thought,” a paper which first appeared in Social Psychological and Personality Science:
Read the rest of this entry »
A former Vanderbilt University biomedical engineer committed fraud on a massive scale, according to a new Office of Research Integrity (ORI) report.
Igor Dzhura is banned from receiving federal funding for three years, and is retracting six papers, which have been cited more than 500 times. Since leaving Vanderbilt, he has worked at SUNY Upstate Medical University, and now works at Novartis.
According to the ORI, Dzhura was a busy boy at Vanderbilt, faking images and drastically inflating the number of experiments he conducted by duplicating computer files and saving them in nested folders. The total body count from his work includes: Read the rest of this entry »
The abstract, “Reduced syntaxin-5 in skeletal muscle of patients with type 2 diabetes is linked to increased diacylglycerol, activation of PKCtheta and impaired insulin signalling,” was presented at the annual meeting of the European Association of the Study of Diabetes. The first author was Kurt Højlund, who now is at the University of Southern Denmark. The second author was Pontus Boström, of the Karolinska Institutet.
Last week, microbiologist Enrico Bucci emailed us with concerns that several of the citations listed on his Google Scholar profile were fake.
Colleagues of his had noticed the same problem on their pages.
The listings seem to be real titles, researchers, and publications, but scrambled. When Bucci first spoke with us, the Scholar citations all linked to clearly fake pages on a site hosted by e-commerce giant Alibaba. You can see an example here (that’s a screenshot on the right). Read the rest of this entry »
A paper by a former postdoc at MD Anderson Cancer Center who “admitted to knowingly and intentionally falsifying” a figure has been retracted.
In August, the Office of Research Integrity announced that it had sanctioned Jun Fu for faking data in a study of the results of a mouse study of NVP-HSP990, a Novartis compound designed to fight brain tumors. Here’s the notice for the study in question, published in Cancer Research:
Read the rest of this entry »
The paper has been cited at least once since the lies came to light, as we reported earlier this month.
The journal contacted the relevant parties on October 29 with the following email about “Degradation of 2,4-dinitroanisole (DNAN) by metabolic cooperative activity of Pseudomonas sp. strain FK357andRhodococcus imtechensis strain RKJ300,” although no notice has been posted: Read the rest of this entry »
Update, 4 p.m. EST, 10/29/14: As a commenter points out, we didn’t quite get this one right. The Boldt paper that has been retracted was not previously retracted for lack of IRB approval. Rather, it was a heretofore unretracted article, from 1996, which German investigators have determined contained faked data. We’ve made edits below using strikethroughs, and have changed the headline to better reflect the content. We apologize for the errors.
We’ve commented before on the fact that we’ve noticed there’s often more to retractions whose stated reason is lack of institutional review board (IRB) approval. We can understand editors’ inclination to act as quickly as possible to issue a retraction, the scientific publishing equivalent of jailing Al Capone for tax evasion. But we appreciate it even more when said editors return to the scene of the crime, as it were, when new important details come out.
Case in point: Anesthesia & Analgesia has amended its retraction of a
2009 1996 study by Joachim Boldt — who with nearly 90 retractions once held the record in that department — based on findings that the data in that paper were fabricated.
The article was titled
“Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy,” “The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patient.” had previously been retracted because Boldt had failed to obtain adequate ethics approval for the research. But now comes this, According to the retraction notice from editor in chief Steven Shafer: Read the rest of this entry »